Robert M. Chanock, M.D.
Affiliations: | Laboratory of Infectious Diseases | NIAID, NIH, Rockville, MD, United States |
Area:
VirologyWebsite:
http://en.wikipedia.org/wiki/Robert_M._ChanockGoogle:
"Robert M. Chanock"Bio:
1924-2010. Discovered parainfluenza virus type 2 (1950-52), RSV (1954-57), three additional parainfluenza viruses, Mycoplasma pneumoniae, several coronaviruses and rhinoviruses. He developed and adenovirus vaccine that was used in the U.S. military. He also worked on dengue and RSV vaccines.
Parents
Sign in to add mentor| Albert B. Sabin | post-doc | 1950-1957 | NIAID, NIH | |
| (Fellowship, junior faculty) | ||||
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vesikari T, Karvonen AV, Majuri J, et al. (2006) Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. The Journal of Infectious Diseases. 194: 370-6 |
| Rumyantsev AA, Chanock RM, Murphy BR, et al. (2006) Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine. 24: 133-43 |
| Kapikian AZ, Simonsen L, Vesikari T, et al. (2005) A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. The Journal of Infectious Diseases. 192: S22-9 |
| Pletnev AG, Claire MS, Elkins R, et al. (2003) Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology. 314: 190-5 |
| CHANOCK RM. (2003) Cytopathogenic effect of Newcastle virus in monkey kidney cultures and interference with poliomyelitis viruses. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 89: 379-81 |
| Murphy BR, Morens DM, Simonsen L, et al. (2003) Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. The Journal of Infectious Diseases. 187: 1301-8 |
| CHANOCK RM. (2002) Association of a new type of cytopathogenic myxovirus with infantile croup. The Journal of Experimental Medicine. 104: 555-76 |
| Hoshino Y, Jones RW, Chanock RM, et al. (2002) Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK. Vaccine. 20: 3576-84 |
| Durbin AP, Karron RA, Sun W, et al. (2001) Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. The American Journal of Tropical Medicine and Hygiene. 65: 405-13 |
| CHANOCK RM, PARROTT RH, COOK K, et al. (2000) Newly recognized myxoviruses from children with respiratory disease. The New England Journal of Medicine. 258: 207-13 |